These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 156502)

  • 1. The dehydroepiandrosterone loading test. III. A possible placental function test.
    Pupkin MJ; Nagey DA; Schomberg DW; MacKenna J; Crenshaw C
    Am J Obstet Gynecol; 1979 Jun; 134(3):281-8. PubMed ID: 156502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A physiologic model of the dehydroepiandrosterone to estrogen conversion system in the fetoplacental unit. II. Preliminary clinical application--the dehydroepiandrosterone loading test.
    Pupkin MJ; Nagey DA; MacKenna J; Schomberg DW; Crenshaw C
    Am J Obstet Gynecol; 1976 May; 125(2):256-62. PubMed ID: 131488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An endocrine model for the diagnosis of intrauterine growth retardation as demonstrated by the determination of total estrogen and pregnandiol 24-hour urinary excretion in 222 at risk pregnancies.
    Wolfrum R; Bordasch C; Holweg J
    J Perinat Med; 1975; 3(4):248-59. PubMed ID: 1225959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dehydroepiandrosterone sulfate tolerance test in high-risk pregnancy as evaluation of feto-placental insufficiency].
    Goisis C; Goisis F; Grossi F
    Minerva Ginecol; 1977 May; 29(5):369-89. PubMed ID: 142931
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis of intrauterine fetal growth retardation (IUGR) and placental insufficiency by a dehydroepiandrosterone sulfate (DHAS) loading test.
    Rabe T; Hösch R; Runnebaum B
    Biol Res Pregnancy Perinatol; 1983; 4(3):130-6. PubMed ID: 6226324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for fetal risk with urinary oestrogen: creatinine ratio at 34 weeks.
    O'Herlihy C; Martin RH
    Br J Obstet Gynaecol; 1980 May; 87(5):388-92. PubMed ID: 7387938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A physiologic model of the dehydroepiandrosterone to estrogen conversion system in the fetoplacental unit. I. Development.
    Nagey DA; Pupkin MJ; MacKenna J; Schomberg DW; Crenshaw C
    Am J Obstet Gynecol; 1976 May; 125(2):249-55. PubMed ID: 131487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the oxytocin challenge test serve as the primary method for managing high-risk pregnancies?
    Hayden BL; Simpson JL; Ewing DE; Otterson WN
    Obstet Gynecol; 1975 Sep; 46(3):251-4. PubMed ID: 1161226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the DHEA-S test at an index of fetoplacental insufficiency.
    Stembera ZK; Herzmann J
    J Perinat Med; 1973; 1(3):192-7. PubMed ID: 4283127
    [No Abstract]   [Full Text] [Related]  

  • 10. [Should we still explore placental sulfatase deficiencies? Reflections apropos of a case report].
    Giovangrandi Y; Magnin G; Sauvanet E; Soutoul JH; Cedard L; Bedin M; Moraine C; Nottin P; Hamard G
    Rev Fr Gynecol Obstet; 1984 Oct; 79(10):653-7. PubMed ID: 6528160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DHA-S-loading test for assessing placentar function with radioimmunologic determination of plasma estrogens (author's transl)].
    Strecker JR; Lauritzen C
    Z Geburtshilfe Perinatol; 1974 Aug; 178(4):254-64. PubMed ID: 4280663
    [No Abstract]   [Full Text] [Related]  

  • 12. [Endocrinologic and enzymologic supervision of pregnancy].
    Brandau H
    Med Klin; 1974 Sep; 69(38):1519-29. PubMed ID: 4280009
    [No Abstract]   [Full Text] [Related]  

  • 13. Incorrect diagnosis of placental insufficiency in a patient with pre-eclampsia.
    Axelsson O; Weiner E
    Acta Obstet Gynecol Scand; 1980; 59(3):281-2. PubMed ID: 6448532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dehydroepiandrosterone loading test. IV. Evaluation of clinical utility.
    Nagey DA; Pupkin MJ; Mandeville L; Schomberg DW; Crenshaw C
    Am J Obstet Gynecol; 1982 Jan; 142(1):60-5. PubMed ID: 6459738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-risk pregnancy management protocol.
    Crane JP; Sauvage JP; Arias F
    Am J Obstet Gynecol; 1976 May; 125(2):227-35. PubMed ID: 1266902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects of the laboratory diagnosis of intrauterine foetal distress.
    Donát J; Jirkalová V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):569-622. PubMed ID: 6972081
    [No Abstract]   [Full Text] [Related]  

  • 17. [Placental ultrasonics and fetal monitorization].
    Comino R; Navarrete L; Chung C; Florido J
    Acta Obstet Ginecol Hisp Lusit; 1977 Mar; 25(3):161-77. PubMed ID: 878856
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dynamic tests of the placental efficiency (author's transl)].
    Muzyczuk Z; Czekanowski R
    Zentralbl Gynakol; 1977; 99(12):748-54. PubMed ID: 899355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin challenge tests and urinary estriols in the management of high-risk pregnancies.
    Curet LB; Olson RW
    Obstet Gynecol; 1980 Mar; 55(3):296-300. PubMed ID: 7360425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perinatal results in cases of EPH gestosis and "small placenta"].
    Philipp K; Skodler WD; Pateisky N
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):301-3. PubMed ID: 3721160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.